Advertisement

Biologia

, Volume 70, Issue 12, pp 1553–1564 | Cite as

Escherichia coli expression of NDV fusion protein gene and determination of its antigenic epitopes

  • Naila Shahid
  • Sana Tahir
  • Abdul Q. RaoEmail author
  • Sameera Hassan
  • Anwar Khan
  • Ayesha Latif
  • Muhammad Au Khan
  • Bushra Tabassum
  • Ahmed A. Shahid
  • Ahmed U. Zafar
  • Tayyab Husnain
Section Cellular and Molecular Biology

Abstract

Recurrent outbreaks of Newcastle disease have questioned the usage of existing vaccines that whether they are still adequate to protect clinical diseases and inhibit virus transmission in poultry. Advancement in molecular biology has led to the production of recombinant vaccines in recent years, which can be a more useful strategy to control infections of Newcastle disease virus (NDV). Studies indicate that the pathogenic nature of NDV is mediated by its membrane associated fusion (F) protein. Here we report the cloning of the full-length F gene-pET30a and its expression in Escherichia coli BL21 DE3 cells through isopropyl β-D-1-thiogalactopyranoside induction. Transferring the protein on nitrocellulose membrane in Western blotting confirmed its specificity with histidine-tagged antibody reaction at the proper size of 67 kDa. Protein purification with nickel charged sepharose column affinity chromatography resulted in a single band of 67 kDa purified His-tag F protein on SDS-PAGE. Analysis of its immunogenicity through bioinformatics tools revealed that more than 70% of its sequence is antigenically active comprising 24 linear immunogenic peptides predicted by the Linear epitope prediction tool and 9 immunogenic peptides predicted by ElliPro. This is a key achievement of the study, which may lead towards recombinant vaccine production in future. In conclusion, our findings suggest that rather than employing live viral vaccines, using a purified immunogenic recombinant F protein as a vaccine or cloning the same gene in a suitable plant vector for production of edible vaccine will provide better protection against the NDV into chicken.

Key words

Newcastle disease virus fusion protein protein expression affinity chromatography recombinant vaccines epitope prediction 

Abbreviations

F

fusion protein

HN

hemagglutinin neuraminidase

IPTG

isopropyl β-D-1-thiogalactopyranoside

LB

Luria Bertani

ND

Newcastle disease

NDV

Newcastle disease virus

PBS

phosphate buffer saline

PI

protrusion index

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Altschul S.F., Gish W., Miller W., Myers E.W. & Lipman D.J. 1990. Basic local alignment search tool. J. Mol. Biol. 215: 403–410.CrossRefGoogle Scholar
  2. Arora P., Lakhchaura B.D. & Garg S.K. 2010. Evaluation of immunogenic potential of 75kDa and 56kDa proteins of newcastle disease virus (NDV). Indian J. Exp. Biol. 48: 889–895.PubMedGoogle Scholar
  3. Benson D.A., Clark K., Karsch-Mizrachi I., Lipman D.J., Ostell J. & Sayers E.W. 2014. GenBank. Nucleic Acids Res 42: D32-D37.Google Scholar
  4. Chang J.Y. 1981. Isolation and characterization of polypeptide at the picomole level. Pre-column formation of peptide derivatives with dimethylaminoazobenzene isothiocyanate. Biochem. J. 199: 537–545.CrossRefGoogle Scholar
  5. Clemmitt R. & Chase H. 2000. Facilitated downstream processing of a histidine-tagged protein from unclarifled E. coli ho-mogenates using immobilized metal affinity expanded-bed adsorption. Biotechnol. Bioeng. 67: 206–216.CrossRefGoogle Scholar
  6. Diel D.G., Miller P.J., Wolf P.C., Mickley R.M., Musante A.R., Emanueli D.C., Shively K.J., Pedersen K. & Afonso C.L. 2012. Characterization of Newcastle disease viruses isolated from cormorant and gull species in the United States in 2010. Avian Dis. 56: 128–133.CrossRefGoogle Scholar
  7. Frozandeh-Moghadam M., R. M., Dehghani M., Mosavi S., Pourbakhsh S. & Golchinfar F. 2009. Cloning & expression of F protein gene (HR1 region) of Newcastle Disease Virus NR43 isolate from Iran in E. coli. Iranian Journal of Virology 3: 16–22.CrossRefGoogle Scholar
  8. Grace D. 2014. The business case for One Health. Onderstepoort Journal of Veterinary Research 81: Art. No. 725.Google Scholar
  9. Guerrero-Andrade O., Loza-Rubio E., Olivera-Flores T., Fehérvári-Bone T. & Gómez-Lim M.A. 2006. Expression of the Newcastle disease virus fusion protein in transgenic maize and immunological studies. Transgenic Res. 15: 455–463.CrossRefGoogle Scholar
  10. Hilleringmann M., Jobst B. & Baudner B.C. 2014. Influenza cell-culture vaccine production, pp. 823–837. In: Giese M. (ed.) Molecular Vaccines, Springer, Cham.Google Scholar
  11. Kapczynski D.R., Afonso C.L. & Miller P.J. 2013. Immune responses of poultry to Newcastle disease virus. Dev. Comp. Immunol. 41: 447–453.CrossRefGoogle Scholar
  12. Khan T.A., Rue C.A., Rehmani S.F., Ahmed A., Wasilenko J.L., Miller P.J. & Afonso C.L. 2010. Phylogenetic and biological characterization of Newcastle disease virus isolates from Pakistan. J. Clin. Microbiol. 48: 1892–1894.CrossRefGoogle Scholar
  13. Kim S.H., Subbiah M., Samuel A.S., Collins P.L. & Samal S.K. 2011. Roles of the fusion and hemagglutinin-neuraminidase proteins in replication, tropism, and pathogenicity of avian paramyxoviruses. J. Virol. 85: 8582–8596.CrossRefGoogle Scholar
  14. Kim S.H., Wanasen N., Paldurai A., Xiao S., Collins P.L. & Samal S.K. 2013. Newcastle disease virus fusion protein is the major contributor to protective immunity of genotype-matched vaccine. PLoS One 8: e74022.CrossRefGoogle Scholar
  15. Kim S.H., Xiao S., Shive H., Collins P.L. & Samal S.K. 2012. Replication, neurotropism, and pathogenicity of avian paramyxovirus serotypes 1–9 in chickens and ducks. PloS One 7: e34927.CrossRefGoogle Scholar
  16. Kurland C. & Gallant J. 1996. Errors of heterologous protein expression. Curr. Opin. Biotechnol. 7: 489–493.CrossRefGoogle Scholar
  17. Laemmli U.K. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227: 680–685.CrossRefGoogle Scholar
  18. Lee Y.J., Sung H.W., Choi J.G., Lee E.K., Yoon H., Kim J.H. & Song C.S. 2008. Protection of chickens from Newcastle disease with a recombinant baculovirus subunit vaccine expressing the fusion and hemagglutinin-neuraminidase proteins. J. Vet. Sci. 9: 301–308.CrossRefGoogle Scholar
  19. Morrison T.G. 2003. Structure and function of a paramyxovirus fusion protein. Biochim. Biophys. Acta 1614: 73–84.CrossRefGoogle Scholar
  20. Paldurai A., Xiao S., Kim S.-H., Kumar S., Nayak B., Samal S., Collins P.L. & Samal S.K. 2014. Effects of naturally occurring six-and twelve-nucleotide inserts on Newcastle disease virus replication and pathogenesis. PLoS One 9: el03951.CrossRefGoogle Scholar
  21. Ponomarenko J., Bui H.H., Li W., Fusseder N., Bourne P.E., Sette A. & Peters B. 2008. ElliPro: a new structure-based tool for the prediction of antibody epitopes. BMC Bioinformatics 9: 514.CrossRefGoogle Scholar
  22. Qiu X., Sun Q., Wu S., Dong L., Hu S., Meng C., Wu Y. & Liu X. 2011. Entire genome sequence analysis of genotype IX Newcastle disease viruses reveals their early-genotype phylogenetic position and recent-genotype genome size. Virol. J. 8: 117.CrossRefGoogle Scholar
  23. Ran X.H., Wen X.B., Zhao X.H. & Liu C.F. 2008. Expression of F and HN protein of NDV in E. coli. Biotechnology 18: 11–13.Google Scholar
  24. Samal S.K. 2011. Newcastle disease and related avian paramyxoviruses, pp. 69–114. In: Samal S.K. (ed.) The Biology of Paramyxoviruses, Caister Academic Press, Norfolk.Google Scholar
  25. Sambrook J., Fritsch E.F. & Maniatis T. 1989. Molecular Cloning. Cold Spring Harbor Laboratory Press, New York.Google Scholar
  26. Satyavathi V., Prasad V., Shaila M. & Sita L.G. 2003. Expression of hemagglutinin protein of Rinderpest virus in transgenic pigeon pea [Cajanus cajan (L.) Millsp.] plants. Plant Cell Rep 21: 651–658.PubMedGoogle Scholar
  27. Subramanian S.K., Tey B.T., Hamid M. & Tan W.S. 2009. Production of the matrix protein of Nipah virus in Escherichia coli: virus-like particles and possible application for diagnosis. J. Virol. Methods 162: 179–183.CrossRefGoogle Scholar
  28. Yusibov V., Streatfleld S.J. & Kushnir N. 2011. Clinical development of plant-produced recombinant pharmaceuticals: vaccines, antibodies and beyond. Hum. Vaccin. 7: 313–321.CrossRefGoogle Scholar
  29. Yusoff K. & Tan W.S. 2001. Newcastle disease virus: macro-molecules and opportunities. Avian Pathol. 30: 439–455.CrossRefGoogle Scholar

Copyright information

© Slovak Academy of Sciences 2015

Authors and Affiliations

  • Naila Shahid
    • 1
  • Sana Tahir
    • 1
  • Abdul Q. Rao
    • 1
    Email author
  • Sameera Hassan
    • 1
  • Anwar Khan
    • 1
  • Ayesha Latif
    • 1
  • Muhammad Au Khan
    • 1
  • Bushra Tabassum
    • 1
  • Ahmed A. Shahid
    • 1
  • Ahmed U. Zafar
    • 1
  • Tayyab Husnain
    • 1
  1. 1.Centre of Excellence in Molecular BiologyUniversity of the PunjabLahorePakistan

Personalised recommendations